340 related articles for article (PubMed ID: 10366795)
1. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
[TBL] [Abstract][Full Text] [Related]
2. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
4. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38--and CD34+49d+ subsets during apheresis.
Bojko P; Scharifi M; Stössel K; Seeber S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):19-28. PubMed ID: 11862468
[TBL] [Abstract][Full Text] [Related]
5. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
[TBL] [Abstract][Full Text] [Related]
6. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
[TBL] [Abstract][Full Text] [Related]
7. CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.
Sampol Mayol A; Besalduch Vital J; Galmés Llodrá A; Bargay Lleonart J; Matamoros Flori N; Morey Sureda M; Novo García A; Mascaró Riera M; Gonzaléz Bach E; Martínez García P
Haematologica; 1998 Jun; 83(6):489-95. PubMed ID: 9676020
[TBL] [Abstract][Full Text] [Related]
8. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
[TBL] [Abstract][Full Text] [Related]
9. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
Hénon PH; Sovalat H; Bourderont D
J Biol Regul Homeost Agents; 2001; 15(1):62-7. PubMed ID: 11388746
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
[TBL] [Abstract][Full Text] [Related]
11. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
12. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.
Drayer AL; Smit Sibinga CT; Esselink MT; de Wolf JT; Vellenga E
Ann Hematol; 2002 Apr; 81(4):192-7. PubMed ID: 11976820
[TBL] [Abstract][Full Text] [Related]
13. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
14. Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients.
Specchia G; Pastore D; Mestice A; Liso A; Carluccio P; Leo M; Casanova M; Sibilla S; Giannoccaro M; Liso V
Acta Haematol; 2006; 116(4):229-37. PubMed ID: 17119322
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
17. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
[TBL] [Abstract][Full Text] [Related]
18. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
[TBL] [Abstract][Full Text] [Related]
20. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]